Stock Events

Stock Events

Xilio Therapeutics (XLO) Q4 2024 Earnings

7NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.72

-0.48

-0.24

0

Details

Expected EPS

-0.246667

Actual EPS

-0.22

Surprise EPS

0.03

Surprise Percent

+10.81%

Description

Xilio Therapeutics (XLO) has reported earnings of -0.22 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.